Top Stories13 hours ago
Edesa Biotech Achieves Breakthrough in ARDS Treatment Study
Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company based in Toronto, has reported promising results from its Phase 3 clinical trial for the drug candidate...